SCHEMBL5503450

SCHEMBL5503450

O=S(=O)(c1ccccc1)N(CCCSc1nc2ccccc2[nH]1)CCc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AR P10275 4/20 0.63
ALDH1A1 P00352 2/20 0.56
LMNA P02545 6/20 0.52
MAPT P10636 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
NPC1 O15118 3/20 0.50
RAB9A P51151 2/20 0.50
BCHE P06276 1/20 0.50
EPHX2 P34913 1/20 0.49
MAOB P27338 1/20 0.48
KMT2A Q03164 1/20 0.47
GRIN2A Q12879 1/20 0.45
GRIN2B Q13224 1/20 0.45
GRIN2C Q14957 1/20 0.45
TP53 P04637 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5503332 0.87 AR (0.63) ARALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL5499298 0.76 AR (0.63) ARALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL5111621 0.76 AR (0.61) ARALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL5114340 0.75 AR (0.60) ARALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL15501170 0.74 LMNA (0.67) ARALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL5504394 0.73 AR (0.58) ARALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL14304932 0.73 BCHE (0.86) ARALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL5499583 0.73 AR (0.55) ARALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL5106111 0.73 PTGDR2 (0.70) KMT2A
SCHEMBL9514166 0.72 ALDH1A1 (1.00) ARALDH1A1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784182-A1 2-SULFANYL-BENZIMIDAZOL-1-YL-ACETIC ACID DERIVATIVES AS CRTH2 ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2007-05-16 EP disclosed
WO-2006021418-A1 2-SULFANYL-BENZOIMIDAZOL-1-YL-ACETIC ACID DERIVATIVES AS CRTH2 ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2006-03-02 WO disclosed